Meadow Creek Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Meadow Creek Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$32K	Hold	4,352	–	–	﹤0.01%	1289
2019 Q2	$40K	Hold	4,352	–	–	﹤0.01%	1296
2019 Q1	$23K	Sell	4,352 -850	-16%	-$4.85K	﹤0.01%	1306
2018 Q4	$23K	Buy	+5,202	New	+$28.5K	﹤0.01%	1256
2018 Q3	–	Sell	-57,868	Closed	-$406K	–	1336
2018 Q2	$406K	Buy	57,868 +2,890	+5%	+$28.4K	0.01%	734
2018 Q1	$782K	Hold	54,978	–	–	0.02%	495
2017 Q4	$482K	Sell	54,978 -6,086	-10%	-$60.2K	0.01%	670
2017 Q3	$714K	Buy	61,064 +3,842	+7%	+$47.1K	0.02%	500
2017 Q2	$799K	Buy	57,222 +22,712	+66%	+$260K	0.02%	466
2017 Q1	$474K	Hold	34,510	–	–	0.01%	557
2016 Q4	$247K	Buy	+34,510	New	+$378K	0.01%	669

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meadow Creek Investment Management's SNDX Position: Q3 2019 in Review

Meadow Creek Investment Management held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2019 at 4,352 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Meadow Creek Investment Management first reported a position in SNDX in Q4 2016 and has held it in 11 quarters since. The position peaked at $799K in Q2 2017. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

Meadow Creek Investment Management held 4,352 shares of Syndax Pharmaceuticals worth $32K as of Q3 2019.
Meadow Creek Investment Management left its Syndax Pharmaceuticals share count unchanged in Q3 2019.
Syndax Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1289 holding.
Meadow Creek Investment Management first reported a position in Syndax Pharmaceuticals in Q4 2016 and has held it in 11 quarters since.
Meadow Creek Investment Management's Syndax Pharmaceuticals position peaked at $799K in Q2 2017.
72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.